P3.13-06 Analysis of ALK Rearrangement Non-Small Cell Lung Cancer Cell Blocks From Pleural Effusion

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1846
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P3.13-16 Concomitant EML4-ALK Rearrangement and EGFR Mutation in Non-Small Cell Lung Cancer Patients: Data From Eastern Indian Hospital.

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.13-07 CUX1-ALK: A Novel ALK Rearrangement That Responds to Crizotinib in Non-Small-Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

PD-L1 and Immunotherapy in Patients With Non-Small Cell Lung Cancer and Malignant Pleural Effusion

2018English

Neoadjuvant Crizotinib in Resectable Locally Advanced Non-Small-Cell Lung Cancer With ALK-rearrangement: A Brief Report

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2019English

The Biology and Treatment of EML4-ALK Non-Small Cell Lung Cancer

European Journal of Cancer
Cancer ResearchOncology
2010English

Tackling ALK in Non-Small Cell Lung Cancer: The Role of Novel Inhibitors

Translational Lung Cancer Research
Oncology
2016English

ALK Inhibition for Non-Small Cell Lung Cancer: From Discovery to Therapy in Record Time

Cancer Cell
Cancer ResearchOncologyCell Biology
2010English

Differential Crizotinib Response Duration Among ALK Fusion Variants in ALK-Positive Non–Small-Cell Lung Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2016English

Non-Small Cell Lung Cancer

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy